EGFR and lung adenocarcinoma: Previous studies have shown that the Asia-Pacific patients with lung adenocarcinoma had the higher EGFR mutation frequency (47% (5958/12819)) and the Oceania patients with lung adenocarcinoma showed the lower EGFR mutation frequency (12% (69/570)) [41].